| Financial Year |
March 31 2023 |
| Monetary Funds |
2,865,886,768.59 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,545,568.08 |
| Accounts Receivable |
1,864,357,765.20 |
| Advances to Suppliers |
72,004,313.20 |
| Other Receivables |
29,854,616.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,345,666,838.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
376,500.00 |
| Other Current Assets |
80,453,445.99 |
| Total Current Assets |
6,540,062,485.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
190,143,177.59 |
| Investment Properties |
18,428,343.20 |
| Fixed Assetes |
2,284,362,419.74 |
| Under-construction Projects |
1,083,415,976.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
237,282,943.63 |
| R&D expenses |
-- |
| Goodwill |
98,216,201.55 |
| Long-Term Deferred and Prepaid Expenses |
127,612,956.10 |
| Deferred Income Tax Assets |
46,215,760.55 |
| Other Non-Current Assets |
14,391,442.49 |
| Sub-Total of Non-Current Assets |
4,464,020,920.03 |
| Total Assets |
11,004,083,405.33 |
| Short-Term Loans |
422,729,524.43 |
| Trading Financial liabilities |
-- |
| Notes Payable |
627,817,973.37 |
| Accounts Payable |
1,447,395,787.61 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
49,739,361.40 |
| Taxes Payable |
32,909,405.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
66,066,021.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,275,055.22 |
| Other Current Liabilities |
11,380,240.83 |
| Sub-Total of Current Liabilities |
2,749,649,180.43 |
| Long-term Loans |
58,267,354.16 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
80,302,270.34 |
| Special Payable |
-- |
| Estimatied Liabilities |
5,042,419.86 |
| Deferred Income Tax Liabilities |
8,566,543.84 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
248,832,290.68 |
| Total Liabilities |
2,998,481,471.11 |
| Paid-In Capital(Or Share Stock) |
1,233,434,416.00 |
| Capital Surplus |
4,579,778,220.58 |
| Surplus Reserve |
172,950,570.61 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,966,091,569.38 |
| Minority Stockholder's Interest |
37,771,239.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,967,830,694.41 |
| Owner's Equity（Stockholder's Equity） |
8,005,601,934.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,004,083,405.33 |
